Emergence of 3D printed dosage forms: opportunities and challenges

MA Alhnan, TC Okwuosa, M Sadia, KW Wan… - Pharmaceutical …, 2016 - Springer
The recent introduction of the first FDA approved 3D-printed drug has fuelled interest in 3D
printing technology, which is set to revolutionize healthcare. Since its initial use, this rapid …

Cardiovascular complications of cancer therapy: best practices in diagnosis, prevention, and management: part 1

…, R Moudgil, T Scarabelli, TM Okwuosa… - Journal of the American …, 2017 - jacc.org
Modern cancer therapy has successfully cured many cancers and converted a terminal
illness into a chronic disease. Because cancer patients often have coexisting heart diseases, …

Cardiovascular disease and breast cancer: where these entities intersect: a scientific statement from the American Heart Association

…, S Dent, L Kondapalli, B Ky, T Okwuosa… - Circulation, 2018 - Am Heart Assoc
Cardiovascular disease (CVD) remains the leading cause of mortality in women, yet many
people perceive breast cancer to be the number one threat to women’s health. CVD and …

A lower temperature FDM 3D printing for the manufacture of patient-specific immediate release tablets

TC Okwuosa, D Stefaniak, B Arafat, A Isreb… - Pharmaceutical …, 2016 - Springer
Purpose The fabrication of ready-to-use immediate release tablets via 3D printing provides
a powerful tool to on-demand individualization of dosage form. This work aims to adapt a …

Fabricating a shell-core delayed release tablet using dual FDM 3D printing for patient-centred therapy

TC Okwuosa, BC Pereira, B Arafat, M Cieszynska… - Pharmaceutical …, 2017 - Springer
Purpose Individualizing gastric-resistant tablets is associated with major challenges for clinical
staff in hospitals and healthcare centres. This work aims to fabricate gastric-resistant 3D …

On demand manufacturing of patient-specific liquid capsules via co-ordinated 3D printing and liquid dispensing

TC Okwuosa, C Soares, V Gollwitzer… - European Journal of …, 2018 - Elsevier
A method for the production of liquid capsules with the potential of modifying drug dose and
release is presented. For the first time, the co-ordinated use of fused deposition modelling (…

[HTML][HTML] Buccal films: A review of therapeutic opportunities, formulations & relevant evaluation approaches

L Shipp, F Liu, L Kerai-Varsani, TC Okwuosa - Journal of Controlled …, 2022 - Elsevier
The potential of the mucoadhesive film technology is hard to ignore, owing to perceived
superior patient acceptability versus buccal tablets, and significant therapeutic opportunities …

Global cardio oncology registry (G-COR): registry design, primary objectives, and future perspectives of a multicenter global initiative

…, M Leja, N Akhter, A Guha, TM Okwuosa… - … Quality and Outcomes, 2023 - Am Heart Assoc
BACKGROUND: Global collaboration in cardio-oncology is needed to understand the
prevalence of cancer therapy-related cardiovascular toxicity in different risk groups, practice …

Permissive cardiotoxicity: the clinical crucible of cardio-oncology

…, S Dent, S Ganatra, GS Beasley, T Okwuosa - Cardio Oncology, 2022 - jacc.org
The field of cardio-oncology was born from the necessity for recognition and management of
cardiovascular diseases among patients with cancer. This need for this specialty continues …

[HTML][HTML] Cardio oncology: Digital innovations, precision medicine and health equity

D Sadler, T Okwuosa, AJ Teske, A Guha… - Frontiers in …, 2022 - frontiersin.org
The rapid emergence of cardio-oncology has resulted in a rapid growth of cardio-oncology
programs, dedicated professional societies sections and committees, and multiple …